Lipometabolism disorders—including dyslipidemia, familial hypercholesterolemia, hypertriglyceridemia, and metabolic syndrome—drive atherosclerotic risk and pancreatitis, making comprehensive testing essential for prevention and targeted therapy. At Southern Medical Supplies Limited (SMSL), we offer a full menu covering fasting and non-fasting lipid panels (total cholesterol, HDL-C, triglycerides, calculated or direct LDL-C, non-HDL-C), apolipoproteins (ApoB, ApoA1), lipoprotein(a), optional lipoprotein subfractions/small dense LDL, remnant cholesterol, lipoprotein electrophoresis or immunoassays, and cardiometabolic risk markers such as hs-CRP, homocysteine, insulin with HOMA-IR, plus thyroid panels to exclude secondary causes and targeted genetic testing for FH (e.g., LDLR, APOB, PCSK9). Our portfolio spans ELISA, chemiluminescent immunoassay, molecular, and automated clinical chemistry platforms from a broad network of trusted partners—EUROIMMUN, Ansh Labs, Randox, Streck, Bio-Rad, Abbott, Roche, Siemens Healthineers, Qiagen, bioMérieux, Cepheid, Werfen, Globe Scientific, ELGA LabWater, LW Scientific, Sebia, LTA SRL, Acrobiotech, MAKOL Innovacion Medica, Rayto Life and Analytical Sciences, Diazyme, Hardy’s Diagnostics, and Teco Diagnostics—delivering the analytical sensitivity, traceability, and reproducibility clinicians need to stratify risk, personalize lipid-lowering therapy, and monitor outcomes with confidence.